Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Misclassification of p16-positive, HPV-negative patients biases de-escalation trials. — SciRadar

Back to results

The Lancet. Oncology

Misclassification of p16-positive, HPV-negative patients biases de-escalation trials.

Jessica T Lovett, Michael T Wotman, Marshall Posner

Published: 202510.1016/S1470-2045(25)00616-3

No abstract available for this study.